SCHEMBL2783288

SCHEMBL2783288

Nc1ccc2c(ccc3cc(N)c(C(O)(C(F)(F)F)C(F)(F)F)cc32)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 5/20 0.43
KDM4E B2RXH2 4/20 0.43
MAPT P10636 3/20 0.43
GAA P10253 3/20 0.43
GLA P06280 2/20 0.43
POLB P06746 2/20 0.43
HPGD P15428 2/20 0.43
ATM Q13315 2/20 0.43
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
KCNJ11 Q14654 4/20 0.39
PLAU P00749 1/20 0.38
TSHR P16473 2/20 0.33
CYP3A4 P08684 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2782879 0.92 KDM4E (0.47) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2782291 0.90 SMN1; SMN2 (0.53) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2784641 0.87 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2782874 0.86 KDM4E (0.47) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2784017 0.85 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2784057 0.85 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2784103 0.84 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2783930 0.84 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2783771 0.83 SMN1; SMN2 (0.53) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2783349 0.82 SMN1; SMN2 (0.46) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 US disclosed
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom AFF2, AFF1, AFF4 SMN1; SMN2 3673/4885MEN1 2546/4885KMT2A 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.